Sirtuin 7 plays an oncogenic role in human osteosarcoma via downregulating CDC4 expression

Wang Wei1,2, Zhang Xiao Jing1,2, Zheng Ke1,2

  • 1Department of Bone and Soft-Tissue Tumor Surgery, Cancer Hospital of China Medical UniversityShenyang 110042, Liaoning Province, PR China.

Insights

Sirtuin 7 (SIRT7) promotes osteosarcoma progression by increasing cell proliferation, migration, and invasion. Targeting SIRT7 could offer a new therapeutic strategy for osteosarcoma patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • The role of Sirtuin 7 (SIRT7) in cancer remains controversial, with varying functions across different cancer types.
  • The specific involvement of SIRT7 in osteosarcoma progression is not yet understood.

Purpose of the Study:

  • To investigate SIRT7 expression levels in osteosarcoma.
  • To explore the biological functions of SIRT7 in osteosarcoma cell processes.
  • To elucidate the underlying molecular mechanisms of SIRT7 action in osteosarcoma.

Main Methods:

  • Quantitative analysis of SIRT7 expression in osteosarcoma tissues and cell lines.
  • Functional assays including proliferation, migration, invasion, tumor formation, and metastasis assays.
  • Mechanistic studies involving histone modification (H3K18ac) and gene transcription (CDC4).

Main Results:

  • SIRT7 expression is significantly elevated in osteosarcoma tissues and cell lines compared to non-tumor controls.
  • Higher SIRT7 levels correlate with a poorer prognosis in osteosarcoma patients.
  • SIRT7 knockdown inhibits osteosarcoma cell proliferation, migration, invasion, tumor formation, and metastasis.
  • SIRT7 promotes osteosarcoma progression by downregulating H3K18ac and inhibiting CDC4 transcription.
  • Silencing CDC4 partially reverses the inhibitory effects of SIRT7 knockdown.

Conclusions:

  • SIRT7 acts as an oncoprotein in osteosarcoma, promoting tumor cell proliferation, migration, and invasion.
  • SIRT7 exerts its oncogenic function by targeting CDC4 transcription via H3K18ac modification.
  • SIRT7 represents a potential therapeutic target for osteosarcoma treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K